Perkins Capital Management’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-7,000
Closed -$226K 113
2021
Q3
$226K Hold
7,000
0.14% 88
2021
Q2
$214K Hold
7,000
0.12% 89
2021
Q1
$213K Buy
+7,000
New +$213K 0.12% 93